rs558813483

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_021098.3(CACNA1H):​c.5974G>A​(p.Gly1992Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000206 in 1,549,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1992R) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.224

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.040793985).
BP6
Variant 16-1219056-G-A is Benign according to our data. Variant chr16-1219056-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 529612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5974G>A p.Gly1992Ser missense_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5974G>A p.Gly1992Ser missense_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5989G>A p.Gly1997Ser missense_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5959G>A p.Gly1987Ser missense_variant Exon 33 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5956G>A p.Gly1986Ser missense_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5956G>A p.Gly1986Ser missense_variant Exon 34 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5941G>A p.Gly1981Ser missense_variant Exon 34 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5935G>A p.Gly1979Ser missense_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5923G>A p.Gly1975Ser missense_variant Exon 33 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5917G>A p.Gly1973Ser missense_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5974G>A p.Gly1992Ser missense_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5923G>A p.Gly1975Ser missense_variant Exon 33 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5896G>A p.Gly1966Ser missense_variant Exon 34 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5974G>A p.Gly1992Ser missense_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.5974G>A non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1893G>A non_coding_transcript_exon_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1022G>A non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3792G>A non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5418G>A non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*915G>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*833G>A non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1553G>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*641G>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*608G>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5923G>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5974G>A non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5941G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1090G>A non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1893G>A 3_prime_UTR_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1022G>A 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3792G>A 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5418G>A 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*915G>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*833G>A 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1553G>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*641G>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*608G>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*1090G>A 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711456.1 linkc.5887+405G>A intron_variant Intron 33 of 33 ENSP00000518769.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152196
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000592
AC:
9
AN:
152012
AF XY:
0.0000246
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000244
Gnomad ASJ exome
AF:
0.000119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000172
Gnomad OTH exome
AF:
0.000232
GnomAD4 exome
AF:
0.0000179
AC:
25
AN:
1397620
Hom.:
0
Cov.:
34
AF XY:
0.0000145
AC XY:
10
AN XY:
689362
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31596
American (AMR)
AF:
0.000280
AC:
10
AN:
35682
Ashkenazi Jewish (ASJ)
AF:
0.0000398
AC:
1
AN:
25156
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35734
South Asian (SAS)
AF:
0.0000505
AC:
4
AN:
79226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47772
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5692
European-Non Finnish (NFE)
AF:
0.00000649
AC:
7
AN:
1078800
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152314
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41566
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.0000346
AC:
2
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Sep 21, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
1.8
DANN
Benign
0.69
DEOGEN2
Benign
0.12
T;.;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.43
T;T;T;.
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.041
T;T;T;T
MetaSVM
Uncertain
-0.099
T
MutationAssessor
Benign
-1.2
N;.;.;.
PhyloP100
-0.22
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.10
N;.;N;N
REVEL
Uncertain
0.38
Sift
Benign
0.49
T;.;T;T
Sift4G
Benign
0.66
T;.;T;T
Polyphen
0.0
B;.;B;B
Vest4
0.015
MutPred
0.22
Gain of phosphorylation at G1992 (P = 0.0057);.;.;.;
MVP
0.76
ClinPred
0.028
T
GERP RS
-0.12
Varity_R
0.071
gMVP
0.22
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs558813483; hg19: chr16-1269056; API